Analyst Ratings
Upgrades, downgrades, and price-target changes from Wall Street firms.
Get trade alerts by text
We text you when insiders, Congress or big funds make new trades. Free.
Piper Sandler Reiterates Overweight Rating on Corebridge Financial
Piper Sandler has reaffirmed its Overweight rating on Corebridge Financial, raising the price target to $40.
Wells Fargo Reiterates Overweight Rating on Corebridge Financial
Wells Fargo maintains an Overweight rating on Corebridge Financial with an increased price target.
Morgan Stanley Reiterates Overweight Rating on Rollins, Inc.
Morgan Stanley has reaffirmed its Overweight rating on Rollins, Inc. with a revised price target of $43.00.
Keefe, Bruyette & Woods Reiterates Outperform Rating on JLL
Keefe, Bruyette & Woods has reiterated its Outperform rating on Jones Lang LaSalle, adjusting the price target to $385.
RBC Capital Reiterates Outperform Rating on Ball Corporation
RBC Capital keeps its Outperform rating on Ball Corporation, lowering its price target to $73.0 from $77.0.
UBS Keeps Buy Rating on Invitation Homes with New Target
UBS has reiterated its Buy rating for Invitation Homes, lowering the price target to $31.00.
Barclays Reiterates Overweight Rating on Invitation Homes Inc.
Barclays keeps its Overweight rating on Invitation Homes with a target of $35.
Wells Fargo Reiterates Overweight Rating on Reinsurance Group of America
Wells Fargo has reiterated its Overweight rating on Reinsurance Group of America, setting a price target of $292.
JP Morgan Reiterates Overweight Rating on Reinsurance Group of America
JP Morgan has reiterated its Overweight rating on Reinsurance Group of America, raising the price target to $297.
TD Cowen Maintains Buy Rating on Revvity, Inc. with $175 Target
TD Cowen has reiterated its Buy rating for Revvity, raising the price target to $175 on October 13, 2026.
Citigroup Reiterates Buy Rating on APi Group Corporation
Citigroup has reaffirmed its Buy rating on APi Group and raised its price target to $55.
RBC Capital Reiterates Outperform Rating on Dynatrace, Inc.
RBC Capital maintains its Outperform rating for Dynatrace with a new price target of $73.00 as of October 12, 2026.
Barclays Maintains Overweight Rating on Dynatrace, Inc.
Barclays has reaffirmed its Overweight rating on Dynatrace, setting a price target of $71.0 on October 13, 2026.
RBC Capital Reiterates Outperform Rating on IDEX Corporation
RBC Capital has reaffirmed its Outperform rating on IDEX Corporation with a price target of $285.
TD Cowen Maintains Buy Rating on Clean Harbors, Inc.
TD Cowen reaffirms its Buy rating for Clean Harbors, raising the price target to $390.
Citigroup Reiterates Buy Rating on Clean Harbors, Inc.
Citigroup has reaffirmed its Buy rating on Clean Harbors, increasing the price target to $378.
Morgan Stanley Reiterates Overweight Rating on Brookfield Infrastructure Partners
Morgan Stanley has reaffirmed its Overweight rating on Brookfield Infrastructure Partners, setting a price target of $48.
BMO Capital Reiterates Outperform Rating on Semtech Corporation
BMO Capital has reiterated its Outperform rating on Semtech with a new price target of $230.
Barclays Reiterates Overweight Rating on Zebra Technologies
Barclays maintains its Overweight rating on Zebra Technologies with a target of $416.00, reflecting a slight increase from the previous target.
Needham Reiterates Buy Rating on Fair Isaac Corporation
Needham has reaffirmed its Buy rating on Fair Isaac Corporation with a new price target of $1,100.
Raymond James Reiterates Outperform Rating on Fair Isaac Corporation
Raymond James has reiterated its Outperform rating on Fair Isaac Corporation with a new price target of $1,230.
RBC Capital Maintains Outperform Rating on Fair Isaac Corporation
RBC Capital has reiterated its Outperform rating on Fair Isaac Corporation and reduced the price target to $1,045.
JP Morgan Maintains Underweight Rating on Fortive Corporation
JP Morgan reiterates its Underweight rating on Fortive with a new price target of $56.
Truist Securities Maintains Buy Rating on Ovintiv Inc.
Truist Securities has reiterated its Buy rating on Ovintiv Inc. with a new price target of $77 on October 12, 2026.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.